Simulations Plus, Inc. (SLP)
USD 34.16
(4.62%)
USD 34.16
(4.62%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 70.01 Million USD | 17.52% |
| 2023 | 59.57 Million USD | 10.52% |
| 2022 | 53.9 Million USD | 16.01% |
| 2021 | 46.46 Million USD | 11.73% |
| 2020 | 41.58 Million USD | 22.43% |
| 2019 | 33.97 Million USD | 14.51% |
| 2018 | 29.66 Million USD | 22.9% |
| 2017 | 24.13 Million USD | 20.86% |
| 2016 | 19.97 Million USD | 9.05% |
| 2015 | 18.31 Million USD | 59.8% |
| 2014 | 11.46 Million USD | 13.8% |
| 2013 | 10.07 Million USD | 6.58% |
| 2012 | 9.44 Million USD | -19.38% |
| 2011 | 11.71 Million USD | 9.41% |
| 2010 | 10.71 Million USD | 17.16% |
| 2009 | 9.14 Million USD | 1.95% |
| 2008 | 8.96 Million USD | 1.24% |
| 2007 | 8.85 Million USD | 51.28% |
| 2006 | 5.85 Million USD | 23.2% |
| 2005 | 4.75 Million USD | -8.72% |
| 2004 | 5.2 Million USD | -5.07% |
| 2003 | 5.48 Million USD | 23.42% |
| 2002 | 4.44 Million USD | 13.52% |
| 2001 | 3.91 Million USD | 7.85% |
| 2000 | 3.62 Million USD | 4.69% |
| 1999 | 3.46 Million USD | 31.06% |
| 1998 | 2.64 Million USD | 6.1% |
| 1997 | 2.49 Million USD | -4.11% |
| 1996 | 2.6 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 14.5 Million USD | -7.22% |
| 2024 Q3 | 18.54 Million USD | 1.31% |
| 2024 Q4 | 18.7 Million USD | 0.65% |
| 2024 Q2 | 18.3 Million USD | 26.24% |
| 2023 Q4 | 15.62 Million USD | -3.73% |
| 2023 Q1 | 11.96 Million USD | 1.96% |
| 2023 FY | 59.57 Million USD | 10.52% |
| 2023 Q2 | 15.75 Million USD | 31.64% |
| 2023 Q3 | 16.23 Million USD | 3.07% |
| 2022 Q1 | 12.41 Million USD | 26.18% |
| 2022 FY | 53.9 Million USD | 16.01% |
| 2022 Q4 | 11.73 Million USD | -21.56% |
| 2022 Q3 | 14.95 Million USD | 1.1% |
| 2022 Q2 | 14.79 Million USD | 19.16% |
| 2021 Q4 | 9.84 Million USD | -22.98% |
| 2021 Q1 | 10.7 Million USD | 12.17% |
| 2021 Q3 | 12.77 Million USD | -2.81% |
| 2021 Q2 | 13.14 Million USD | 22.86% |
| 2021 FY | 46.46 Million USD | 11.73% |
| 2020 Q4 | 9.54 Million USD | -22.43% |
| 2020 FY | 41.58 Million USD | 22.43% |
| 2020 Q1 | 9.4 Million USD | 17.13% |
| 2020 Q2 | 10.34 Million USD | 10.09% |
| 2020 Q3 | 12.29 Million USD | 18.82% |
| 2019 Q1 | 7.53 Million USD | 12.68% |
| 2019 Q2 | 8.47 Million USD | 12.42% |
| 2019 Q3 | 9.93 Million USD | 17.3% |
| 2019 Q4 | 8.02 Million USD | -19.23% |
| 2019 FY | 33.97 Million USD | 14.51% |
| 2018 Q4 | 6.68 Million USD | -21.81% |
| 2018 Q2 | 7.35 Million USD | 4.07% |
| 2018 FY | 29.66 Million USD | 22.9% |
| 2018 Q1 | 7.06 Million USD | 12.81% |
| 2018 Q3 | 8.55 Million USD | 16.26% |
| 2017 Q3 | 6.74 Million USD | 18.28% |
| 2017 Q2 | 5.7 Million USD | 5.31% |
| 2017 Q1 | 5.41 Million USD | 36.9% |
| 2017 FY | 24.13 Million USD | 20.86% |
| 2017 Q4 | 6.26 Million USD | -7.15% |
| 2016 FY | 19.97 Million USD | 9.05% |
| 2016 Q1 | 4.83 Million USD | 30.36% |
| 2016 Q2 | 5.16 Million USD | 6.72% |
| 2016 Q4 | 3.95 Million USD | -34.17% |
| 2016 Q3 | 6.01 Million USD | 16.43% |
| 2015 Q2 | 4.57 Million USD | 11.94% |
| 2015 Q1 | 4.08 Million USD | 104.53% |
| 2015 FY | 18.31 Million USD | 59.8% |
| 2015 Q3 | 5.94 Million USD | 29.9% |
| 2015 Q4 | 3.71 Million USD | -37.53% |
| 2014 Q3 | 3.74 Million USD | 21.39% |
| 2014 FY | 11.46 Million USD | 13.8% |
| 2014 Q1 | 2.64 Million USD | 68.46% |
| 2014 Q2 | 3.08 Million USD | 16.68% |
| 2014 Q4 | 1.99 Million USD | -46.59% |
| 2013 Q3 | 3.09 Million USD | -0.75% |
| 2013 FY | 10.07 Million USD | 6.58% |
| 2013 Q1 | 2.29 Million USD | 39.65% |
| 2013 Q2 | 3.11 Million USD | 36.16% |
| 2013 Q4 | 1.56 Million USD | -49.34% |
| 2012 Q3 | 2.77 Million USD | -0.64% |
| 2012 FY | 9.44 Million USD | -19.38% |
| 2012 Q1 | 2.24 Million USD | 6.03% |
| 2012 Q2 | 2.78 Million USD | 24.08% |
| 2012 Q4 | 1.63 Million USD | -40.83% |
| 2011 Q1 | 2.81 Million USD | 27.43% |
| 2011 Q3 | 3.43 Million USD | 2.67% |
| 2011 Q2 | 3.34 Million USD | 19.14% |
| 2011 Q4 | 2.12 Million USD | -38.35% |
| 2011 FY | 11.71 Million USD | 9.41% |
| 2010 FY | 10.71 Million USD | 17.16% |
| 2010 Q4 | 2.2 Million USD | -29.27% |
| 2010 Q3 | 3.11 Million USD | 5.74% |
| 2010 Q2 | 2.94 Million USD | 21.04% |
| 2010 Q1 | 2.43 Million USD | 32.47% |
| 2009 Q1 | 2.13 Million USD | 16.18% |
| 2009 Q4 | 1.83 Million USD | -32.2% |
| 2009 Q3 | 2.71 Million USD | 10.45% |
| 2009 FY | 9.14 Million USD | 1.95% |
| 2009 Q2 | 2.45 Million USD | 15.17% |
| 2008 FY | 8.96 Million USD | 1.24% |
| 2008 Q4 | 1.83 Million USD | -38.14% |
| 2008 Q3 | 2.96 Million USD | 36.18% |
| 2008 Q2 | 2.17 Million USD | 9.87% |
| 2008 Q1 | 1.98 Million USD | -11.29% |
| 2007 Q2 | 2.53 Million USD | 73.97% |
| 2007 Q3 | 2.63 Million USD | 3.84% |
| 2007 Q4 | 2.23 Million USD | -15.01% |
| 2007 FY | 8.85 Million USD | 51.28% |
| 2007 Q1 | 1.45 Million USD | -17.54% |
| 2006 Q1 | 818.81 Thousand USD | -33.43% |
| 2006 FY | 5.85 Million USD | 23.2% |
| 2006 Q3 | 1.78 Million USD | 20.68% |
| 2006 Q2 | 1.48 Million USD | 80.97% |
| 2006 Q4 | 1.76 Million USD | -1.23% |
| 2005 Q4 | 1.22 Million USD | -13.65% |
| 2005 FY | 4.75 Million USD | -8.72% |
| 2005 Q2 | 1.03 Million USD | -3.25% |
| 2005 Q3 | 1.42 Million USD | 38.06% |
| 2005 Q1 | 1.06 Million USD | -27.25% |
| 2004 Q1 | 1.13 Million USD | -43.81% |
| 2004 Q4 | 1.46 Million USD | 18.87% |
| 2004 Q3 | 1.23 Million USD | -9.9% |
| 2004 Q2 | 1.36 Million USD | 20.2% |
| 2004 FY | 5.2 Million USD | -5.07% |
| 2003 Q2 | 1.12 Million USD | 3.95% |
| 2003 Q1 | 1.07 Million USD | -10.95% |
| 2003 Q3 | 1.26 Million USD | 12.55% |
| 2003 Q4 | 2.02 Million USD | 60.76% |
| 2003 FY | 5.48 Million USD | 23.42% |
| 2002 Q4 | 1.2 Million USD | 8.04% |
| 2002 FY | 4.44 Million USD | 13.52% |
| 2002 Q3 | 1.11 Million USD | 1.21% |
| 2002 Q2 | 1.1 Million USD | 9.86% |
| 2002 Q1 | 1 Million USD | 22.89% |
| 2001 FY | 3.91 Million USD | 7.85% |
| 2001 Q4 | 819.66 Thousand USD | -15.86% |
| 2001 Q3 | 974.16 Thousand USD | -8.31% |
| 2001 Q2 | 1.06 Million USD | 0.39% |
| 2001 Q1 | 1.05 Million USD | 7.86% |
| 2000 FY | 3.62 Million USD | 4.69% |
| 2000 Q1 | 813.91 Thousand USD | -15.81% |
| 2000 Q4 | 981.16 Thousand USD | 32.14% |
| 2000 Q3 | 742.52 Thousand USD | -32.0% |
| 2000 Q2 | 1.09 Million USD | 34.16% |
| 1999 Q2 | 800 Thousand USD | -11.11% |
| 1999 Q1 | 900 Thousand USD | 6.49% |
| 1999 FY | 3.46 Million USD | 31.06% |
| 1999 Q3 | 900 Thousand USD | 12.5% |
| 1999 Q4 | 966.8 Thousand USD | 7.42% |
| 1998 Q2 | 500 Thousand USD | 0.0% |
| 1998 FY | 2.64 Million USD | 6.1% |
| 1998 Q3 | 700 Thousand USD | 40.0% |
| 1998 Q4 | 845.15 Thousand USD | 20.74% |
| 1998 Q1 | 500 Thousand USD | -27.86% |
| 1997 FY | 2.49 Million USD | -4.11% |
| 1997 Q3 | 600 Thousand USD | 0.0% |
| 1997 Q2 | 600 Thousand USD | 0.0% |
| 1997 Q4 | 693.1 Thousand USD | 15.52% |
| 1997 Q1 | 600 Thousand USD | 0.0% |
| 1996 FY | 2.6 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Augmedix, Inc. | 44.85 Million USD | -56.087% |
| OneMedNet Corporation | 1.02 Million USD | -6752.927% |
| Minerva Surgical, Inc. | 50.29 Million USD | -39.207% |
| CareCloud, Inc. | 117.05 Million USD | 40.19% |
| CareCloud, Inc. | 117.05 Million USD | 40.19% |
| HealthEquity, Inc. | 999.58 Million USD | 92.996% |
| iCoreConnect Inc. | 8.15 Million USD | -758.888% |
| Progyny, Inc. | 1.08 Billion USD | 93.569% |
| Renalytix Plc | 2.28 Million USD | -2958.672% |
| Schrödinger, Inc. | 216.66 Million USD | 67.686% |
| SOPHiA GENETICS SA | 62.37 Million USD | -12.252% |
| Omnicell, Inc. | 1.14 Billion USD | 93.897% |
| BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 99.207% |
| Streamline Health Solutions, Inc. | 22.59 Million USD | -209.847% |
| Inovalon Holdings, Inc. | 667.52 Million USD | 89.512% |
| Ontrak, Inc. | 12.74 Million USD | -449.423% |
| Nutex Health, Inc. | 247.64 Million USD | 71.729% |
| GE HealthCare Technologies Inc. | 19.55 Billion USD | 99.642% |
| Sharecare, Inc. | 445.25 Million USD | 84.276% |
| Aclarion, Inc. | 75.4 Thousand USD | -92750.512% |
| CareMax, Inc. | 751.1 Million USD | 90.679% |
| Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -107612.308% |
| Forian Inc. | 20.48 Million USD | -241.838% |
| Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -107612.308% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 202.56 Million USD | 65.437% |
| SCWorx Corp. | 3.8 Million USD | -1740.054% |
| Definitive Healthcare Corp. | 251.41 Million USD | 72.152% |
| 10x Genomics, Inc. | 618.72 Million USD | 88.684% |
| Zhongchao Inc. | 19.43 Million USD | -260.261% |
| Accolade, Inc. | 414.29 Million USD | 83.101% |
| MSP Recovery, Inc. | 7.7 Million USD | -808.67% |
| R1 RCM Inc. | 2.25 Billion USD | 96.894% |
| Spok Holdings, Inc. | 139.02 Million USD | 49.64% |
| Privia Health Group, Inc. | 1.65 Billion USD | 95.777% |
| EUDA Health Holdings Limited | 3.7 Million USD | -1788.946% |
| TruBridge, Inc. | 339.43 Million USD | 79.374% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 99.207% |
| Sharecare, Inc. | 445.25 Million USD | 84.276% |
| Health Catalyst, Inc. | 295.93 Million USD | 76.342% |
| GoodRx Holdings, Inc. | 750.26 Million USD | 90.668% |
| Premier, Inc. | 1.34 Billion USD | 94.8% |
| HealthStream, Inc. | 279.06 Million USD | 74.911% |
| Certara, Inc. | 354.33 Million USD | 80.241% |
| GeneDx Holdings Corp. | 202.56 Million USD | 65.437% |
| Ontrak, Inc. | 12.74 Million USD | -449.423% |
| SHL Telemedicine Ltd. | 57.07 Million USD | -22.668% |
| CareCloud, Inc. | 117.05 Million USD | 40.19% |
| EUDA Health Holdings Limited | 3.7 Million USD | -1788.946% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 731.49 Thousand USD | -9471.247% |
| CareMax, Inc. | 751.1 Million USD | 90.679% |
| Healthcare Triangle, Inc. | 33.2 Million USD | -110.863% |
| National Research Corporation | 148.58 Million USD | 52.879% |
| Aclarion, Inc. | 75.4 Thousand USD | -92750.512% |
| OptimizeRx Corporation | 71.52 Million USD | 2.109% |